3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
19
Carcinoma, Non-Small-Cell Lung
9
Rhabdomyosarcoma
6
Triple Negative Breast Neoplasms
5
Hodgkin Disease
4
Recurrence
3
Neoplasms
3
Uterine Cervical Neoplasms
2
Sarcoma
2
Rhabdomyosarcoma, Embryonal
2
Rhabdomyosarcoma, Alveolar
2
Neoplasm Metastasis
2
Lung Neoplasms
2
Adenocarcinoma
2
Solitary Fibrous Tumor, Pleural
1
NSCLC
1
Metastatic HER2-positive Breast Cancer
1
Mesothelioma, Malignant
1
Lung Diseases, Interstitial
1
Locally Advanced Non-Small Cell Lung Cancer
1
HR+HER2- Breast Cancer
1
HER2-negative Metastatic Breast Cancer
1
Fludzoparib" and Anti-angiogenic
1
Desmoplastic Small Round Cell Tumor
1
Colonic Neoplasms
1
Carcinoma, Squamous Cell
1
Carcinoma, Large Cell
1
Advanced Breast Cancer
1
Interventions
Carboplatin
9
pembrolizumab
7
Pemetrexed
7
Radiotherapy
5
Magnetic Resonance Spectroscopy
5
Specimen Handling
4
Radiation
4
Nivolumab
4
Bevacizumab
4
Platinum
3
Paclitaxel
3
Mastectomy, Segmental
3
Cisplatin
3
Biopsy
3
fludarabine phosphate
2
durvalumab
2
capmatinib
2
aldesleukin
2
Taxes
2
Radiotherapy, Conformal
2
Radiosurgery
2
Ipilimumab
2
Interleukin-2
2
Immunoglobulin G
2
Disulfides
2
Cyclophosphamide
2
CTLA-4 Antigen
2
Anterior Temporal Lobectomy
2
1,2-diaminocyclohexaneplatinum II citrate
2
veliparib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Adenocarcinoma of Lung
×
Vinorelbine
×
1 year
×
Clear all
No trials found.